HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none

(2016) Mariam El-Zein et al.   JOURNAL OF CLINICAL VIROLOGY

Use of Cytology, E6/E7 mRNA, and p16INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening

(2015) Daniela Gustinucci et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years

(2015) Matejka Rebolj et al.   EUROPEAN JOURNAL OF CANCER

Transitioning to a new era in cervical cancer screening

(2015) Mark Schiffman et al.   GYNECOLOGIC ONCOLOGY

Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance

(2015) Warner K. Huh et al.   GYNECOLOGIC ONCOLOGY

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

FDA approves new upgraded Gardasil 9

(2015) Tony Kirby   LANCET ONCOLOGY

New standard of care—HPV testing for cervical cancer screening

(2015) Philip E. Castle   Nature Reviews Clinical Oncology

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus

(2015) Natalie Kash et al.   Journal of Clinical Medicine

Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors

(2013) Salvatore Vaccarella et al.   EUROPEAN JOURNAL OF CANCER

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

(2013) F. Xavier Bosch et al.   VACCINE

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

(2012) Debbie Saslow et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

(2012) G S Ogilvie et al.   BRITISH JOURNAL OF CANCER

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

(2012) John T. Schiller et al.   VACCINE

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada

(2012) G.S. Ogilvie et al.   VACCINE

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

(2010) Gina S Ogilvie et al.   BMC CANCER

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

(2009) Henry C Kitchener et al.   LANCET ONCOLOGY

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3

(2008) Laura Kotaniemi-Talonen et al.   EUROPEAN JOURNAL OF CANCER